Multivariable analysis of variables associated with increased risk for NRM
| Parameter . | HR . | 95% CI . | P . | Global P . |
|---|---|---|---|---|
| Conditioning regimen | ||||
| Myeloablative | 1.0 | |||
| RIC/NMA | 1.5 | 1.1-2.1 | .024 | |
| Bilirubin at enrollment, mg/dL | ||||
| ≤2 | 1.0 | |||
| >2 | 2.24 | 1.16-4.34 | .017 | |
| Skin score at enrollment | ||||
| Not involved | 1.0 | .004 | ||
| Mild | 1.21 | 0.72-2.05 | .47 | |
| Moderate or severe | 1.89 | 1.27-2.82 | .002 | |
| Lung score at enrollment | ||||
| Not involved | 1.0 | .002 | ||
| Mild | 1.68 | 1.14-2.49 | .009 | |
| Moderate or severe | 2.25 | 1.35-3.75 | .002 | |
| Walk test (per 10 feet) | 0.97 | 0.96-0.99 | .001 | |
| Modified HAP-adjusted activity score (per 10 points) | 0.80 | 0.70-1.0 | .012 |
| Parameter . | HR . | 95% CI . | P . | Global P . |
|---|---|---|---|---|
| Conditioning regimen | ||||
| Myeloablative | 1.0 | |||
| RIC/NMA | 1.5 | 1.1-2.1 | .024 | |
| Bilirubin at enrollment, mg/dL | ||||
| ≤2 | 1.0 | |||
| >2 | 2.24 | 1.16-4.34 | .017 | |
| Skin score at enrollment | ||||
| Not involved | 1.0 | .004 | ||
| Mild | 1.21 | 0.72-2.05 | .47 | |
| Moderate or severe | 1.89 | 1.27-2.82 | .002 | |
| Lung score at enrollment | ||||
| Not involved | 1.0 | .002 | ||
| Mild | 1.68 | 1.14-2.49 | .009 | |
| Moderate or severe | 2.25 | 1.35-3.75 | .002 | |
| Walk test (per 10 feet) | 0.97 | 0.96-0.99 | .001 | |
| Modified HAP-adjusted activity score (per 10 points) | 0.80 | 0.70-1.0 | .012 |